TWiV 1078: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin reviews recent measles outbreaks, prequalification of nOPV2 by the WHO and most recent statistics on the circulation of respiratory syncytial virus, influenz...
13 Jan 20241h 11min
TWiV 1079: Rock of phages
TWiV reveals how viruses participate in the organomineralization of travertines, and how neutralizing antibodies evolve to exploit vulnerable sites in the hepatitis C virus envelope glycoprotein E2 an...
13 Jan 20241h 46min
TWiV 1077: EtOH and viruses at McGill
Vincent travels to McGill University in Montreal, Canada to join Angela for a discussion of the careers and the research of two faculty members, Corinne Maurice and Jesse Shapiro, and their PhD traine...
7 Jan 20241h 45min
TWiV 1076: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin highlights global circulation of Mpox virus, reviews the most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-C...
6 Jan 202427min
TWiV 1075: Fit viruses, parasites, sick chickens
For the last episode of 2023, TWiV describes how ancient chicken remains reveal the increase of fitness and virulence of Marek's disease virus, and the diversity and dissemination of Leishmania virus ...
31 Dec 20231h 53min
TWiV 1074: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses the outcomes of SARS-CoV-2, influenza and respiratory syncytial virus infection in pediatric communities under the age of 18 years, the treatment o...
30 Dec 202345min
TWiV 1073: Taming the shrew and barring Epstein-Barr virus
TWiV explains a study showing that ost traits shape virome composition and virus transmission in wild bats, rodents, and shrews, and development of a gB nanoparticle vaccine that elicits a protective ...
24 Dec 20231h 38min
TWiV 1072: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses the annual economic burden of respiratory syncytial virus in adults in the US, recombinant or standard-dose influenza vaccine in adults under 65 yea...
23 Dec 202338min
